Inotuzumab, CAS 1660159-36-3

Product Description: Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Aujla A, et al. Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res. 2019 Apr 11;7:9.

CAS Number: 1660159-36-3

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody;CD22

• Artikelnummer: MEXHY-P99264-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99264-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK